Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF3299

Introduced
4/7/25  

Caption

Community pharmacy reimbursement fair pricing requirement provision

Impact

The enactment of SF3299 is expected to enhance patient access to pharmacy services while simultaneously bolstering the financial viability of community pharmacies. By setting reimbursement standards, the bill aims to prevent below-cost reimbursements and negative adjustments that could undermine community pharmacies. Prohibiting such practices will provide these pharmacies with the financial support necessary to continue operating effectively, thereby reinforcing their role in the healthcare system, particularly in rural and underserved areas.

Summary

SF3299 is a legislative act aimed at ensuring fair pricing in reimbursement for community pharmacies in Minnesota. The bill mandates that the total reimbursement for any prescription drug dispensed by a community pharmacy must meet or exceed either the National Average Drug Acquisition Cost (NADAC) or, if NADAC is unavailable, the Wholesale Acquisition Cost (WAC). Additionally, it includes a requirement for a professional dispensing fee that is adjusted biennially based on a cost-of-dispensing survey to account for inflation and operational expenses.

Contention

During discussions surrounding the bill, notable contention emerged regarding the practices of pharmacy benefit managers (PBMs) and managed care organizations (MCOs). The bill seeks to establish parity in reimbursement, preventing PBM-owned pharmacies from being reimbursed at higher rates than community pharmacies for the same drug under similar conditions. This aspect of the bill is crucial as it addresses the existing disparities within pharmacy reimbursement frameworks, advocating for a level playing field that could impact how PBMs operate moving forward. Stakeholders indicate that while the bill may enhance community pharmacy operations, some are concerned about potential pushback from PBMs, which could challenge the bill's implementation and effectiveness.

Companion Bills

MN HF3922

Similar To Fair pricing in community pharmacy reimbursement required.

Previously Filed As

MN HF3922

Fair pricing in community pharmacy reimbursement required.

MN HF4140

Minnesota Community Pharmacy Patient Access and Fair Reimbursement Act established, and rulemaking required.

MN S3212

"New Jersey Pharmacy Fair Reimbursement and Anti-Steering Act."

MN LD180

An Act Regarding Reimbursements by Health Insurance Carriers or Pharmacy Benefits Managers to Pharmacies

MN SF4062

Prohibit the use of spread pricing by pharmacy benefit managers

MN HB2081

Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

MN HB2208

Pharmacists; pharmacies; reimbursement costs; appeals

MN HB2196

Pharmacists; pharmacies; reimbursement costs; appeals

MN HB866

Prohibits pharmacy benefit managers and managed care plans from reducing pharmacy reimbursements (OR +$11,093,778 SG EX See Note)

MN HB1236

Provides relative to pharmacy benefit managers reimbursements (RE1 +$2,265,844 SG EX See Note)

Similar Bills

AZ HB2196

Pharmacists; pharmacies; reimbursement costs; appeals

AZ HB2208

Pharmacists; pharmacies; reimbursement costs; appeals

TX HB2978

Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.

TX SB1354

Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.

HI HB2225

Relating To Health.

IA SF383

A bill for an act relating to pharmacy benefits managers, pharmacies, prescription drugs, and pharmacy services administrative organizations, and including applicability provisions. (Formerly SSB 1074.) Effective date: 07/01/2025. Applicability date: 07/01/2025.

IA HSB99

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See HF 852.)

IA SSB1074

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs and including applicability provisions.(See SF 383.)